Evidence map›Paper›PMID 39702939›Full record

ArticleEnvironmental microbiology2024

Optimal Cell Length for Exploration and Exploitation in Chemotactic Planktonic Bacteria.

Òscar Guadayol, Rudi Schuech, Stuart Humphries

Abstract read
In one paragraph

Article in Environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Òscar GuadayolMediterranean Institute for Advanced Studies, IMEDEA (UIB-CSIC), Esporles, Spain.ORCID https://orcid.org/0000-0001-9552-1041
Rudi SchuechDepartment of Mechanical Engineering, Santa Clara University, Santa Clara, California, USA.ORCID https://orcid.org/0000-0002-3533-0582
Stuart HumphriesSchool of Life Sciences, Joseph Banks Laboratories, University of Lincoln, Lincoln, UK.ORCID https://orcid.org/0000-0001-9766-6404

Funding

Gordon and Betty Moore Foundation 6852Leverhulme Trust RLA RL-2012-022'María Zambrano' Program (University of the Balearic Islands)
6 · The paper itself

Abstract

Elongated morphologies are prevalent among motile bacterioplankton in aquatic systems. This is often attributed to enhanced chemotactic ability, but how long is best? We hypothesized the existence of an optimal cell length for efficient chemotaxis resulting from shape-imposed physical constraints acting on the trade-off between rapid exploration versus efficient exploitation of nutrient sources. To test this hypothesis, we evaluated the chemotactic performance of elongated cephalexin-treated Escherichia coli towards α-methyl-aspartate in a microfluidic device creating linear, stable and quiescent chemical gradients. Our experiments showed cells of intermediate length aggregating most tightly to the chemoattractant source. A sensitivity analysis of an Individual-Based-Model replicating these results showed that 1) cells of intermediate length are optimal at transient states, whereas at steady state longest cells are best, 2) poor chemotactic performance of very short cells is caused by directionality loss, and 3) long cells are penalized by brief, slow runs. Finally, we evaluated chemotactic performance of cells of different length with simulations of a phycosphere, and found that long cells swimming in a run-and-reverse pattern with extended runs and moderate speeds are most efficient in this microenvironment. Overall, our results suggest that the stability of the chemical landscape plays a role in cell-size selection.

Indexed as

ChemotaxisEscherichia coliPlanktonCephalexinCephalexinaquatic microbiologybacterial shapechemotaxisEscherichia coliindividual‐based modelsmicrobial individual based ecologyphycosphere

Identifiers

PMID39702939
PMCPMC11659635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.